Physiologic Pacing Registry

  • Research type

    Research Study

  • Full title

    Physiologic Pacing Registry

  • IRAS ID

    281799

  • Contact name

    Rebecca Malpass

  • Contact email

    rebecca.malpass@abbott.com

  • Clinicaltrials.gov Identifier

    NCT03719040

  • Duration of Study in the UK

    1 years, 6 months, 22 days

  • Research summary

    Electrical conduction allows for the heart to pump and maintain the pace required for a person to function normally. Patients with cardiac disease and heart failure associated to abnormal electrical conduction of the heart may benefit from a therapy that resynchronises the heart to pump blood more efficiently. This is called cardiac resynchronization therapy (CRT).
    A CRT-P is a pacemaker, but like a mini computer that is specialised for managing heart failure. A pacemaker functions to replace the work of a persons heart’s natural pacemaker, the sinus node. With a pacemaker’s help, the heart can maintain a normal, healthy rhythm so it can circulate the amount of blood needed to meet the body’s need. A CRT-D is a type of specialized implantable cardioverter defibrillator (ICD) that manages heart failure by sending electrical impulses to synchronize the heart's chambers and sending an electrical shock to the heart if needed.
    Physiologic pacing is a multi-centre, prospective registry and this registry will be conducted to gain a deeper understanding of the physiologic device implants and follow-up workflows, including device and programmer measurements to help inform Abbott’s product and clinical data development efforts.
    The registry will include patients scheduled for implantation of an Abbott CRT pacemaker (CRT-P) or CRT defibrillator (CRT-D) and who meet all inclusion/exclusion criteria. Participants will be followed in-clinic at baseline (before implant), implant, and at 1 month and 6 months after the date of successful implant.

  • REC name

    West of Scotland REC 4

  • REC reference

    20/WS/0171

  • Date of REC Opinion

    13 Apr 2021

  • REC opinion

    Further Information Favourable Opinion